why choose us

First received: April 21, 2023

Clinical Trial: An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cystic Fibrosis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Placebo- and Positive-controlled, Thorough QT/QTc Study of Vanzacaftor Monotherapy in Healthy Subjects

Brief Summary: The purpose of this study is to evaluate the effect of Vanzacaftor (VNZ) on QTcF, as well as the pharmacokinetic (PK), safety, and tolerability of VNZ in healthy participants.

Read more